Endocrinology · Medical Literature
Pre-exercise meal macronutrient composition and acute inflammatory response in males with type 2 diabetes mellitus.
Abstract
Type 2 diabetes mellitus (T2DM) is associated with chronically increased inflammation related to insulin resistance and endothelial dysfunction. Meal macronutrient consumption and physical activity generate acute effects on circulating inflammatory markers in the general population. We aimed to assess the impact of macronutrient composition on the acute inflammatory response to exercise in male adults with T2DM. Ten males with well-controlled T2DM completed five moderate-intensity exercise sessions in a single-blind crossover design under five conditions: 1) fasting and, 2 h after a standardized meal enriched in 2) 22 g sucrose, 3) 22 g fructose, 4) 15 g fat, and 5) aspartame. Blood samples were taken before, during, and after exercise at 15-minute intervals. Levels of C-reactive protein (CRP) were analyzed. Protocol was registered on ClinicalTrials.gov (NCT07175740). CRP levels remained unchanged during the exercise and recovery periods in all conditions. CRP levels were higher in the fructose condition compared to sucrose and fasting conditions. The inflammatory response to exercise in males with T2DM may be independent of the macronutrient composition of the diet. A meal enriched in fructose could lead to an inflammatory response in these individuals.
Clinical relevance
Does the macronutrient composition of a standardized pre-exercise meal (sucrose, fructose, fat, or aspartame) differentially affect the acute C-reactive protein (CRP) inflammatory response to moderate-intensity exercise in adult males with well-controlled type 2 diabetes mellitus compared to fasting exercise? __SNAPSHOT__ {"studyDesign":"Single-blind, randomized crossover trial (5-condition within-subject design)","setting":"Not reported (country and institution type not specified in abstract); registered on ClinicalTrials.gov (NCT07175740)","sampleSize":"n=10 (male adults with well-controlled T2DM; single-arm crossover, all participants completed all 5 conditions)","population":"Adult males with well-controlled type 2 diabetes mellitus; other inclusion/exclusion criteria (e.g., age range, HbA1c thresholds, medication use, BMI) not reported in abstract","intervention":"Five moderate-intensity exercise sessions each performed under a distinct pre-exercise condition: (1) fasting; (2) 2 hours after a meal enriched with 22 g sucrose; (3) 2 hours after a meal enriched with 22 g fructose; (4) 2 hours after a meal enriched with 15 g fat; (5) 2 hours after a meal containing aspartame (non-caloric control)","comparator":"Crossover design with fasting as the reference condition; aspartame served as a non-caloric sweetener comparator; each participant served as their own control across all 5 conditions","primaryOutcome":"Serum C-reactive protein (CRP) levels measured before, during, and after exercise at 15-minute intervals (acute inflammatory response to exercise)","followUp":"Acute/within-session measurement only; inter-session washout period not reported","fundingSource":"Not reported"}
Key findings
CRP levels did not change significantly during the exercise or recovery periods in any of the five pre-exercise conditions (fasting, sucrose, fructose, fat, aspartame). This null finding was consistent across all macronutrient exposures, indicating that acute exercise-related CRP kinetics were not modified by pre-meal macronutrient type. However, a between-condition difference in baseline or overall CRP levels was observed: CRP levels were higher in the fructose condition compared to both the sucrose and fasting conditions. Specific CRP values (means, standard deviations), p-values, confidence intervals, and effect sizes for all comparisons are not reported in the abstract. NNT/NNH cannot be calculated from the data provided. No adverse events are described in the abstract.
Practice implications
This study provides pilot-level evidence suggesting that the acute CRP response to moderate-intensity exercise in well-controlled male T2DM patients is independent of whether exercise is performed fasted or 2 hours after meals enriched with sucrose, fructose, fat, or aspartame. The finding that CRP did not change acutely during or after exercise in any condition aligns with the known kinetic behavior of CRP as a slowly responding acute-phase reactant (half-life ~19 hours), raising the methodological question of whether CRP is the most sensitive or appropriate marker to detect acute, exercise-related inflammatory dynamics within a single exercise session. The observation that baseline or overall CRP was elevated in the fructose condition relative to sucrose and fasting warrants careful interpretation: it may reflect a pre-existing or postprandial pro-inflammatory effect of fructose that is distinct from any acute exercise-induced change, but the temporal relationship and clinical magnitude are not quantified in the abstract. These findings cannot be extrapolated to females, older or younger populations, insulin-treated patients, patients with poorly controlled T2DM, or those with comorbid conditions. The study does not address other inflammatory biomarkers (e.g., IL-6, TNF-α, IL-1β), which may be more dynamically responsive to acute exercise. IMPORTANT LIMITATION: This summary is based exclusively on the published abstract; full methodology, complete statistical results, figures, and supplementary data have not been reviewed. __LIMITATIONS__ Very small sample size (n=10), severely limiting statistical power, precision of estimates, and generalizability; the study is substantially underpowered to detect moderate or even large between-condition differences in CRP,Single-sex cohort (males only); findings cannot be generalized to females or non-binary individuals with T2DM,CRP is a slowly responding acute-phase protein with a half-life of approximately 19 hours; it is a biologically inappropriate marker for detecting acute, within-session inflammatory responses to a single exercise bout, which may explain the null finding and constitutes a significant biomarker selection limitation,Only one inflammatory marker (CRP) measured; no data on more kinetically appropriate acute-phase markers (IL-6, IL-1β, TNF-α, leukocytes, or monocyte activation),Single-blind design; full blinding of participants may have been impossible for all conditions (e.g., taste differences between aspartame vs. sucrose vs. fructose vs. fat), introducing potential performance or expectation bias,Exercise intensity described as 'moderate' without specification of absolute or relative workload (e.g., % VO₂max, METs, or heart rate zone), limiting reproducibility,Inter-session washout period and sequence randomization details not reported in the abstract; carryover effects cannot be assessed,Characterization of 'well-controlled T2DM' not defined (no HbA1c range, diabetes duration, or medication class specified), limiting clinical applicability,Macronutrient doses (22 g sucrose, 22 g fructose, 15 g fat) may not reflect real-world pre-exercise meal patterns; the ecological validity of the standardized meal conditions is uncertain,Funding source not disclosed; potential conflicts of interest cannot be assessed,Abstract-only availability: full statistical reporting, methods, randomization details, and adverse event data cannot be evaluated __BOTTOM_LINE_CATEGORY__ promising_but_preliminary __BOTTOM_LINE__ In this very small (n=10) single-blind crossover pilot trial of males with well-controlled T2DM, acute CRP levels did not change during or after moderate-intensity exercise regardless of pre-exercise macronutrient condition (fasting, sucrose, fructose, fat, or aspartame), suggesting the acute CRP response to exercise may be independent of pre-meal macronutrient composition. The finding of higher CRP in the fructose condition relative to sucrose and fasting is hypothesis-generating but cannot be acted upon clinically given the limited sample size, single-sex cohort, absence of statistical detail, and the biologic unsuitability of CRP as an acute exercise inflammatory marker. Adequately powered, multi-biomarker trials in diverse T2DM populations are required before any clinical or dietary guidance can be derived from these results.